Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pharmacyclics reports phase I results for Lu-Tex

May 22, 1997

Interim results with Pharmacyclics' Gd-Tex reported at ASCO

May 22, 1997

Encouraging results reported for ImClone's lead cancer therapeutic agent

May 22, 1997

Onyx reports clinical results of anticancer viral therapeutic at ASCO meeting

May 22, 1997

Diaziridinylpolyamines as anticancer agents claimed by U. of Maryland

May 22, 1997

Aronex reports clinical progress of Annamycin

May 21, 1997

Preliminary phase I/II results for Vertex's VX-710

May 21, 1997

Gensia receives ANDA approval for etoposide injection

May 21, 1997

Update on Onconase clinical trials

May 20, 1997

Purdue Pharma licenses anticancer chimeric

May 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...